2nd booster of Pfizer/BioNTech and Moderna COVID-19 vaccines – Expanded emergency use authorization
March 29, 2022 - The FDA announced an expanded emergency use authorization (EUA) for Pfizer/BioNTech and Moderna COVID-19 vaccines authorizing use of a second booster dose that may be administered to individuals 50 years of age and older at least 4 months after receipt of a first booster dose of any authorized or approved COVID-19 vaccine.
Top